Literature DB >> 1801544

Selegiline hydrochloride and cognition.

A J Lees1.   

Abstract

Selegiline HCl, 10 mg per day has been reported to improve attention and episodic memory in Parkinson's disease and early Alzheimer's disease. Selegiline also improves motor reaction times in Parkinson's and subjective feelings of increased vitality, euphoria and energy. At doses of between 10 and 40 mg a day it has also been shown to improve depression particularly when psychomotor retardation is prominent and anxiety minimal.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1801544     DOI: 10.1111/j.1600-0404.1991.tb05027.x

Source DB:  PubMed          Journal:  Acta Neurol Scand Suppl        ISSN: 0065-1427


  3 in total

1.  Does selegiline delay progression of Parkinson's disease? A critical re-evaluation of the DATATOP study.

Authors:  C D Ward
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-02       Impact factor: 10.154

Review 2.  Rasagiline and rapid symptomatic motor effect in Parkinson's disease: review of literature.

Authors:  Michele Pistacchi; Francesco Martinello; Manuela Gioulis; Sandro Zambito Marsala
Journal:  Neurol Ther       Date:  2013-12-17

Review 3.  Monoamine oxidase inhibitors. A perspective on their use in the elderly.

Authors:  H P Volz; C H Gleiter
Journal:  Drugs Aging       Date:  1998-11       Impact factor: 4.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.